In conclusion, by employing clinical samples and a series in vitro and in vivo experiments, we preliminary explored the mechanism by which TRIM21 regulating DNA replication through TCF3/MCM2/5 axis, and eventually affecting CRC development and chemosensitivity to replication inhibitors. This evidence concerns the gene MCM2 and colorectal carcinoma.